SALT LAKE CITY, April 14, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on a review of the evolving role of hyperthermia titled, "Current Status of Clinical Trials for Cancer Utilizing Hyperthermia as an Adjuvant for Radiation/Chemotherapy," which was presented by Dr. Ellen Jones, PhD, MD, Clinical Associate Professor, Duke University Medical Center, Department of Radiation, at the annual Society for Thermal Medicine (STM) meeting that was held in Tucson, Arizona from April 4 to April 7, 2009. Dr. Jones reviewed the evolving clinical role of hyperthermia, as evidenced by the recent and ongoing clinical studies on hyperthermia. The main studies reviewed included studies utilizing hyperthermia to treat breast cancer patients who present with recurrent disease, studies using hyperthermia in conjunction with both radiation and chemotherapy to treat advanced cervical cancer patients, and studies using hyperthermia to deliver targeted and controlled doses of chemotherapy to the tumor.
